Pharmacoeconomic research of medicines used for allergic rhinitis in children

Simple item page
dc.contributor.authorSuyunov, Nen_US
dc.contributor.authorUmurzakhova, Gen_US
dc.contributor.authorBlatov, Ren_US
dc.contributor.authorYegizbayeva, Sen_US
dc.contributor.authorAbdullaeva, Men_US
dc.contributor.authorZhakipbekov, Ken_US
dc.date.accessioned2024-11-30T11:21:20Z
dc.date.available2024-11-30T11:21:20Z
dc.date.issued2024-09
dc.description.abstractAllergic rhinitis (AR) is a common global disease, affecting approximately 2%–25% of children and 1%–40% of adults. Recent studies have shown an increasing prevalence, especially in low-income countries. Although not fatal, AR significantly impairs patients’ quality of life and is linked to bronchial asthma (BA) development. This research aimed to study the regional distribution of AR in children, analyze various medicine preparations used for treatment, and identify effective and affordable options through pharmaco-economic methods. Data from the Ministry of Healthcare of the Republic of Uzbekistan, Hospital No. 2 of the Tashkent Medical Academy, and wholesale medicine costs were analyzed. The study demonstrated the effectiveness and cost efficiency of budesonide medicines for treating AR in children with BA, resulting in significant cost savings during the first treatment session.en_US
dc.identifier.affiliationsDepartment of Organization of Pharmaceutical Business, Tashkent Pharmaceutical Institute, Tashkent, Uzbekistanen_US
dc.identifier.affiliationsDepartment of Organization and Management of Pharmaceutical Business, South Kazakhstan Medical Academy, Shymkent, Kazakhstanen_US
dc.identifier.affiliationsDepartment of Pharmacy, Kazakh-Russian Medical University, Almaty, Kazakhstanen_US
dc.identifier.affiliationsDepartment of Organization of Management and Economics of Pharmacy and Clinical Pharmacy, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstanen_US
dc.identifier.affiliationsDepartment of Allergology, Republican Scientific Specialized Allergology Center, Tashkent, Uzbekistanen_US
dc.identifier.affiliationsDepartment of Organization of Management and Economics of Pharmacy and Clinical Pharmacy, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.en_US
dc.identifier.citationSuyunov N, Umurzakhova G, Blatov R, Yegizbayeva S, Abdullaeva M, Zhakipbekov K. Pharmacoeconomic research of medicines used for allergic rhinitis in children. Journal of Applied Pharmaceutical Science. 2024 Sept; 14(9): 198-207en_US
dc.identifier.issn2231-3354
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/237698
dc.languageenen_US
dc.publisherOpen Science Publishers LLPen_US
dc.relation.issuenumber9en_US
dc.relation.volume14en_US
dc.source.urihttps://doi.org/10.7324/JAPS.2024.163331en_US
dc.subjectBudesonideen_US
dc.subjectmebhydrolinen_US
dc.subjectchloropyramineen_US
dc.subjectbudesonide mometazone furoateen_US
dc.subjectmedicines substances.en_US
dc.titlePharmacoeconomic research of medicines used for allergic rhinitis in childrenen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
japs2024v14n9p198.pdf
Size:
424.41 KB
Format:
Adobe Portable Document Format
Download
Collections
Journal of Applied Pharmaceutical Science (JAPS)